Prenetics revenue soars 288% to $46.5 million in Q2

• Prenetics reported Q2 2026 revenue of $46.5 million, up about 288% year over year, with IM8 contributing $45 million.
• PRE shares were up 0.83% at $19.53 in premarket trading shortly after the results were released.
• Prenetics raised FY2026 IM8 revenue guidance to $220–$230 million and introduced FY2027 guidance of more than $400 million.

Prenetics (NASDAQ:PRE) reported Q2 2026 revenue of $46.5 million, up about 288% year over year, while IM8 revenue reached $45 million.

Total revenue landed within Prenetics' $46–$48 million guidance, while IM8 revenue met its $44–$46 million forecast and marked a sixth consecutive record quarter.

IM8 generated $20.9 million in July revenue, which Prenetics said represents an annualized revenue run-rate of approximately $251 million.

Following the announcement, Prenetics' share price was up 0.83% at $19.53 in premarket trading.

Prenetics said July was its first month of positive consolidated Adjusted Free Cash Flow and expects the measure to remain positive from Q3 onward.

The company raised FY2026 IM8 revenue guidance to $220–$230 million and said it expects more than $400 million of IM8 revenue in FY2027.